Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Pieris Pharmaceuticals Inc | PIRS | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
11,64 | 11,62 | 11,90 | 11,71 | 11,71 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
14.2.2024 | 22:37 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
14.2.2024 | 19:12 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
14.2.2024 | 15:19 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
02.2.2024 | 15:59 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
21.12.2023 | 22:30 | EDGAR2 | Form 8-K - Current report |
14.11.2023 | 22:02 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
31.8.2023 | 22:15 | EDGAR2 | Form 8-K/A - Current report: [Amend] |
10.8.2023 | 23:04 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
10.8.2023 | 22:24 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
18.7.2023 | 15:15 | EDGAR2 | Form 8-K - Current report |
13.7.2023 | 13:30 | EDGAR2 | Form 8-K - Current report |